Detalhe da pesquisa
1.
Guselkumab demonstrates long-term efficacy and maintenance of treatment response post-withdrawal in systemic-treatment naïve patients and non-responders to fumaric acid esters: Results from parts II and III of a randomised, active-comparator-controlled phase IIIb trial (POLARIS).
Br J Dermatol
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133615
2.
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial.
Br J Dermatol
; 187(4): 507-514, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35553043
3.
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis.
J Drugs Dermatol
; 21(2): 162-171, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133113
4.
Self-efficacy, burnout and academic success in nursing students: A counterfactual mediation analysis.
J Adv Nurs
; 78(10): 3217-3224, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35307859
5.
Molecular Cross-Talk between Gravity- and Light-Sensing Mechanisms in Euglena gracilis.
Int J Mol Sci
; 23(5)2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269918
6.
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Aesthet Surg J
; 42(12): 1460-1469, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922149
7.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Aesthet Surg J
; 40(4): 413-429, 2020 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30951166
8.
Indikation zur Systemtherapie bei chronischer Prurigo: Kommentierte Checkliste für die Praxis.
J Dtsch Dermatol Ges
; 21(7): 822-824, 2023 07.
Artigo
em Alemão
| MEDLINE | ID: mdl-37427739
9.
Indication for systemic therapy in chronic prurigo: Annotated checklist for practice.
J Dtsch Dermatol Ges
; 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723931
10.
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle Behandlungssituationen.
J Dtsch Dermatol Ges
; 16(6): 806-814, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873903
11.
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2 - Special patient populations and treatment situations.
J Dtsch Dermatol Ges
; 16(6): 806-813, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873906
12.
S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.
J Dtsch Dermatol Ges
; 16(5): 645-669, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750443
13.
An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds.
Dermatol Surg
; 43(1): 58-65, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27673483
14.
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.
J Am Acad Dermatol
; 75(1): 99-105, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27021239
15.
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations.
J Dtsch Dermatol Ges
; 19(6): 934-150, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139083
16.
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 1: Therapieziele und Therapieempfehlungen.
J Dtsch Dermatol Ges
; 19(6): 934-951, 2021 Jun.
Artigo
em Alemão
| MEDLINE | ID: mdl-34139080
17.
Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm - Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidität.
J Dtsch Dermatol Ges
; 19(7): 1092-1117, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288473
18.
German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situations.
J Dtsch Dermatol Ges
; 19(7): 1092-1115, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288477
19.
S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie.
J Dtsch Dermatol Ges
; 16(5): 645-670, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750455
20.
S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
J Dtsch Dermatol Ges
; 10 Suppl 2: S1-95, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22386073